TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20670088

Group type: EXPERIMENTAL
Intervention: Subcutaneous injections of different allergens for 24 months
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Subcutaneous injections of different allergens for 18 months
Number of subjects: 36
Study: 16938099

Group type: EXPERIMENTAL
Intervention: Stabilization appliance
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control appliance
Number of subjects: 60
Study: 12956739

Group type: EXPERIMENTAL
Intervention: MPL-adjuvanted grass pollen allergy vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 10849983

Group type: EXPERIMENTAL
Intervention: Arm-rest immobilization
Number of subjects: 30

Group type: COMPARATOR
Intervention: Vacuum bag immobilization
Number of subjects: 30
Study: 9354313

Group type: EXPERIMENTAL
Intervention: TAK-044 25 mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: TAK-044 50 mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: TAK-044 100 mg
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 1342112

Group type: EXPERIMENTAL
Intervention: Chloroquine 50 mg/Kg
Number of subjects: 124

Group type: COMPARATOR
Intervention: Chloroquine 25 mg/Kg
Number of subjects: 124
Study: 3007066

Group type: EXPERIMENTAL
Intervention: Bone marrow transplantation
Number of subjects: 15

Group type: COMPARATOR
Intervention: Total‐body radiation (3.6 Gy)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Cyclosporin A administration
Number of subjects: 15

Group type: COMPARATOR
Intervention: Buffy‐coat transfusion
Number of subjects: 15

Group type: COMPARATOR
Intervention: Antithymocyte globulin
Number of subjects: 15
Study: 29577826

Group type: EXPERIMENTAL
Intervention: Pain-relieved nursing home residents
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Fear of falling
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Effective pain treatment
Number of subjects: 239
Study: 30237219

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate treatment
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study: 26845317

Group type: EXPERIMENTAL
Intervention: 3 mW/cm2 for 30 minutes
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 9 mW/cm2 for 10 minutes
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 18 mW/cm2 for 5 minutes
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 30 mW/cm2 for 3 minutes
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 45 mW/cm2 for 2 minutes
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control for group-A
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control for group-B
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control for group-C
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control for group-D
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control for group-E
Number of subjects: 25
Study: 25178809

Group type: EXPERIMENTAL
Intervention: Prednisolone
Number of subjects: 1400

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1400

Group type: EXPERIMENTAL
Intervention: M. indicus pranii
Number of subjects: 1400
Study: 22621300

Group type: EXPERIMENTAL
Intervention: Structured Telephonic Counselling (STC)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Conventional Counselling (C)
Number of subjects: 114
Study: 19242897

Group type: EXPERIMENTAL
Intervention: Experimental Group (EG) - group therapy consisting of psychoeducation, cognitive restructuring, stress management, relaxation and mindfulness techniques.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control Group (CG) - wait-list control with no intervention during the waiting period.
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Experimental Group (EG) - group therapy.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control Group (CG) - wait-list control.
Number of subjects: 40
Study: 18055982

Group type: EXPERIMENTAL
Intervention: Daily deferiprone (DFP) 75 mg/kg plus desferrioxamine (DFO) 40-50 mg/kg twice weekly
Number of subjects: 24

Group type: COMPARATOR
Intervention: Daily deferiprone (DFP) monotherapy
Number of subjects: 24

Group type: COMPARATOR
Intervention: Desferrioxamine (DFO) 40-50 mg/kg 5 days weekly (reference group)
Number of subjects: 24
Study: 16581423

Group type: EXPERIMENTAL
Intervention: Ranibizumab (Lucentis) at doses ranging from 0.3 to 2.0 mg, administered via 5, 7, or 9 intravitreal injections at 2- or 4-week intervals for 16 weeks.
Number of subjects: 32
Study: 14566118

Group type: EXPERIMENTAL
Intervention: Patient simulator
Number of subjects: 60

Group type: COMPARATOR
Intervention: Moulage patient
Number of subjects: 60
Study: 11556039

Group type: EXPERIMENTAL
Intervention: Tamoxifen alone
Number of subjects: 88
Study: 8669669

Group type: EXPERIMENTAL
Intervention: Normothermic oxygenated blood cardioplegia (33.5 degrees C)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Hypothermic oxygenated blood cardioplegia (10 degrees C)
Number of subjects: 42
Study: 1607678

Group type: EXPERIMENTAL
Intervention: 5% topical minoxidil
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (vehicle alone)
Number of subjects: 20
Study: 2863148

Group type: EXPERIMENTAL
Intervention: Metoprolol (15 mg intravenous followed by 200 mg daily oral for 15 days)
Number of subjects: 5778

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 5778

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5778
Study: 29956886

Group type: COMPARATOR
Intervention: Control VOO (80 mg kg‐1)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: FVOO (500 mg kg‐1)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: FVOOT (500 mg kg‐1; 1:1)
Number of subjects: 33
Study: 27194033

Group type: EXPERIMENTAL
Intervention: Guided self-help (6 hours of professional support)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Computerized CBT (1 hour of professional support)
Number of subjects: 36
Study: 24813588

Group type: EXPERIMENTAL
Intervention: Older infants (16-18 months)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Younger infants (12-14 months)
Number of subjects: 40
Study: 22307201

Group type: EXPERIMENTAL
Intervention: Compensatory oculomotor reading training
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Compensatory oculomotor visual exploration training
Number of subjects: 36

Group type: COMPARATOR
Intervention: Training sequence
Number of subjects: 36
Study: 20222114

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided corticosteroid injection
Number of subjects: 184

Group type: COMPARATOR
Intervention: CE-guided corticosteroid injection
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Accurate injections
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: US guidance
Number of subjects: 184

Group type: COMPARATOR
Intervention: CE guidance
Number of subjects: 184
Study: 19100058

Group type: EXPERIMENTAL
Intervention: Nadroparin 0.075 ml/10 kg (group I, n = 120)
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Nadroparin 0.1 ml/10 kg (group II, n = 116)
Number of subjects: 236
Study: 15812629

Group type: EXPERIMENTAL
Intervention: ITBV guided fluid therapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: CVP guided fluid therapy
Number of subjects: 40
Study: 12529074

Group type: EXPERIMENTAL
Intervention: Recent drinking history (RDH) measured using daily diary and timeline followback methods
Number of subjects: 110

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 110
Study: 10349473

Group type: EXPERIMENTAL
Intervention: Immunohistochemical expression of respiratory syncytial virus
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Immunohistochemical staining
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Inflammatory lesions related to RSV
Number of subjects: 53
Study: 8953876

Group type: EXPERIMENTAL
Intervention: Epidural buprenorphine (0.2 mg) after combined spinal-epidural anesthesia (CSE group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Epidural buprenorphine (0.2 mg) after general anesthesia combined with epidural anesthesia (EPI + GEN group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups (CSE and EPI + GEN)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CSE group
Number of subjects: 0
Study: 1941406

Group type: EXPERIMENTAL
Intervention: SMA preterm formula containing 50% medium-chain triglycerides (MCT)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: SMA preterm formula containing 86% long-chain triglycerides (LCT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: S-26 full-term infant formula containing 98% LCT
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: SMA preterm formula containing 50% MCT
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: SMA preterm formula containing 86% LCT
Number of subjects: 20
Study: 6977837

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid, 1 gm daily, and anticoagulants
Number of subjects: 142

Group type: COMPARATOR
Intervention: No antithrombotic drugs
Number of subjects: 142
Study: 30929097

Group type: EXPERIMENTAL
Intervention: Higher PB CD34+ progenitor cell numbers
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Higher PB CD133+ progenitor cell numbers
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Bone marrow progenitor cell numbers
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Relative BM and PB progenitor cell numbers
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: PB and BM progenitor cell numbers
Number of subjects: 160
Study: 28282794

Group type: EXPERIMENTAL
Intervention: Kinesio taping
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo taping
Number of subjects: 30
Study: 25595470

Group type: EXPERIMENTAL
Intervention: Diuretic treatment in acute decompensated heart failure (specific diuretic details not provided).
Number of subjects: 1088
Study: 23279139

Group type: EXPERIMENTAL
Intervention: Aggressive heart failure therapy
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Risk model for predicting nonresponse
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Risk model validation using BATTLESCARRED cohort
Number of subjects: 151
Study: 21976561

Group type: EXPERIMENTAL
Intervention: Intervention not specified; control group not specified
Number of subjects: 3044

Group type: EXPERIMENTAL
Intervention: Artemisinin combination treatment
Number of subjects: 3044
Study: 18678461

Group type: EXPERIMENTAL
Intervention: Internet-based education
Number of subjects: 147

Group type: COMPARATOR
Intervention: Face-to-face education with a nurse
Number of subjects: 147
Study: 17065639

Group type: EXPERIMENTAL
Intervention: Resume anticoagulation
Number of subjects: 608

Group type: COMPARATOR
Intervention: Stop anticoagulation
Number of subjects: 608

Group type: COMPARATOR
Intervention: Normal D-dimer level
Number of subjects: 608

Group type: EXPERIMENTAL
Intervention: Abnormal D-dimer level (stop anticoagulation)
Number of subjects: 608

Group type: EXPERIMENTAL
Intervention: Abnormal D-dimer level (resume anticoagulation)
Number of subjects: 608
Study: 12899797

Group type: EXPERIMENTAL
Intervention: Pre-operative chemotherapy (1-2 cycles of cisplatinum-based regimen)
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Post-operative chemotherapy (2-4 cycles of cisplatinum-based regimen)
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Pre-operative chemotherapy (1-2 cycles) in stage II NSCLC
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Pathological 'T' down stage or unchanged after pre-operative CT
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Responders to pre-operative chemotherapy
Number of subjects: 211

Group type: COMPARATOR
Intervention: Control group (no pre-operative chemotherapy)
Number of subjects: 211
Study: 11885179

Group type: EXPERIMENTAL
Intervention: 3+ mm diameter implants
Number of subjects: 2917

Group type: EXPERIMENTAL
Intervention: 4+ mm diameter implants
Number of subjects: 2917

Group type: EXPERIMENTAL
Intervention: 7 mm length implants
Number of subjects: 2917

Group type: EXPERIMENTAL
Intervention: 16 mm length implants
Number of subjects: 2917
Study: 8614498

Group type: COMPARATOR
Intervention: 0.1 mmol/kg gadolinium-DTPA (standard dose)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 0.3 mmol/kg gadolinium-DTPA (triple dose)
Number of subjects: 22
Study: 1410165

Group type: EXPERIMENTAL
Intervention: Self-administered smoking re-exposure (smoking five cigarettes)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group (remained abstinent)
Number of subjects: 67
Study: 2856773

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (HCTZ) 12.5 mg once daily
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (HCTZ) 25 mg once daily
Number of subjects: 48

Group type: COMPARATOR
Intervention: Enalapril 20 mg once daily
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 31397274

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF) innovator product CellCept
Number of subjects: 0

Group type: COMPARATOR
Intervention: Renodapt (generic)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mycept (generic)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cellmune (generic)
Number of subjects: 0
Study: 27824237

Group type: EXPERIMENTAL
Intervention: Focal extracorporeal shock wave therapy (f‐ESWT) plus supervised eccentric training (SET) of the shoulder abductor muscles
Number of subjects: 22

Group type: COMPARATOR
Intervention: Focal extracorporeal shock wave therapy (f‐ESWT) only
Number of subjects: 22
Study: 27619826

Group type: EXPERIMENTAL
Intervention: Housing First + Assertive Community Treatment (HF+ACT)
Number of subjects: 197

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 197
Study: 26621399

Group type: EXPERIMENTAL
Intervention: ONSTEP technique
Number of subjects: 188

Group type: COMPARATOR
Intervention: Laparoscopic approach
Number of subjects: 188
Study: 23486136

Group type: EXPERIMENTAL
Intervention: Rib plating with the Synthes Matrix Rib Plating System
Number of subjects: 117

Group type: COMPARATOR
Intervention: No rib plating (Control)
Number of subjects: 117
Study: 19010976

Group type: EXPERIMENTAL
Intervention: Verbal threat condition; specific details on dosage and duration not available.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Baseline condition; specific details on dosage and duration not available.
Number of subjects: 0
Study: 18594042

Group type: EXPERIMENTAL
Intervention: Invasive strategy
Number of subjects: 10150
Study: 16845901

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 14679274

Group type: EXPERIMENTAL
Intervention: Intra-articular hyaluronic acid
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Highest-molecular-weight hyaluronic acid
Number of subjects: 22
Study: 11505247

Group type: EXPERIMENTAL
Intervention: Complementary therapies (CTs) course for nursing assistants
Number of subjects: 0
Study: 9760815

Group type: EXPERIMENTAL
Intervention: Ischaemic kidney (renal vein blood)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Normal kidney (renal vein blood)
Number of subjects: 16
Study: 8156566

Group type: EXPERIMENTAL
Intervention: Tooth-brushing (group II)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Deproteinizing (group III)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Intact surface organic material (group I)
Number of subjects: 30
Study: 3048103

Group type: EXPERIMENTAL
Intervention: Ritodrine
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Both drugs together
Number of subjects: 120
Study: 31901945

Group type: EXPERIMENTAL
Intervention: Inpatient multimodal occupational rehabilitation (I‐MORE)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Outpatient acceptance and commitment therapy (O‐ACT)
Number of subjects: 166
Study: 31753694

Group type: EXPERIMENTAL
Intervention: Savoring
Number of subjects: 468

Group type: EXPERIMENTAL
Intervention: Rose, Thorn, Bud
Number of subjects: 468

Group type: COMPARATOR
Intervention: Three Hard Things
Number of subjects: 468

Group type: COMPARATOR
Intervention: Neutral control
Number of subjects: 468
Study: 28533306

Group type: EXPERIMENTAL
Intervention: Bendamustine-rituximab combination therapy
Number of subjects: 45
Study: 25908462

Group type: EXPERIMENTAL
Intervention: COSSACS - Continuation of prestroke antihypertensive therapy
Number of subjects: 942

Group type: EXPERIMENTAL
Intervention: CHHIPS - BP-lowering intervention
Number of subjects: 942
Study: 23417664

Group type: EXPERIMENTAL
Intervention: Multidimensional Treatment Foster Care (MTFC)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Group Care (GC)
Number of subjects: 166
Study: 22590838

Group type: EXPERIMENTAL
Intervention: Insulin + Metformin (500 mg tablets, two per twelve hours)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Insulin + Metformin
Number of subjects: 100

Group type: COMPARATOR
Intervention: Insulin + Placebo
Number of subjects: 100
Study: 19541717

Group type: EXPERIMENTAL
Intervention: Regular chest physiotherapy
Number of subjects: 20

Group type: COMPARATOR
Intervention: No chest physiotherapy
Number of subjects: 20
Study: 16905220

Group type: EXPERIMENTAL
Intervention: Glycyrrhizin (6x weekly)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Glycyrrhizin (3x weekly)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Glycyrrhizin (once weekly)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Glycyrrhizin treatment
Number of subjects: 121
Study: 15534928

Group type: EXPERIMENTAL
Intervention: Intravenous pantoprazole
Number of subjects: 102

Group type: COMPARATOR
Intervention: Ranitidine
Number of subjects: 102
Study: 11728145

Group type: EXPERIMENTAL
Intervention: TNK‐tPA
Number of subjects: 16949

Group type: COMPARATOR
Intervention: rt‐PA
Number of subjects: 16949
Study: 9158573

Group type: EXPERIMENTAL
Intervention: Group outpatient visits (n = 160)
Number of subjects: 321

Group type: COMPARATOR
Intervention: Usual care (n = 161)
Number of subjects: 321
Study: 7713125

Group type: EXPERIMENTAL
Intervention: Endopyelotomy
Number of subjects: 46

Group type: COMPARATOR
Intervention: Pyeloplasty
Number of subjects: 46
Study: 31798953

Group type: EXPERIMENTAL
Intervention: Occupational therapy (hand osteoarthritis education, assistive devices, CMCJ orthoses, and exercises)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group (only hand osteoarthritis information)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Occupational therapy
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 180
Study: 29974634

Group type: EXPERIMENTAL
Intervention: Aspirin as an adjunct to compression therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 26248498

Group type: EXPERIMENTAL
Intervention: Caffeine + EAA
Number of subjects: 8
Study: 24857251

Group type: EXPERIMENTAL
Intervention: Nicardipine
Number of subjects: 223

Group type: COMPARATOR
Intervention: Labetalol
Number of subjects: 223
Study: 22441863

Group type: EXPERIMENTAL
Intervention: CT in the trauma room
Number of subjects: 1124

Group type: COMPARATOR
Intervention: CT in the radiology department
Number of subjects: 1124

Group type: EXPERIMENTAL
Intervention: CT in the trauma room (multiple trauma subgroup)
Number of subjects: 1124

Group type: EXPERIMENTAL
Intervention: CT in the trauma room (TBI subgroup)
Number of subjects: 1124
Study: 21322823

Group type: EXPERIMENTAL
Intervention: Rivastigmine therapy
Number of subjects: 25
Study: 19128556

Group type: EXPERIMENTAL
Intervention: Orthopaedic surgeons
Number of subjects: 60

Group type: COMPARATOR
Intervention: Physicians
Number of subjects: 60
Study: 15797646

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 128

Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 128
Study: 12182952

Group type: EXPERIMENTAL
Intervention: Intraduodenal infusion of glucose
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Intraduodenal infusion of fat
Number of subjects: 14

Group type: COMPARATOR
Intervention: Comparison between lean and obese subjects
Number of subjects: 14
Study: 10359029

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF), 1000 mg/m2/d
Number of subjects: 67

Group type: COMPARATOR
Intervention: Azathioprine (AZA), 2 mg/kg on the first post-operative day
Number of subjects: 67
Study: 8557012

Group type: EXPERIMENTAL
Intervention: Continuous infusion of rocuronium (9.9 +/- 1.3 micrograms kg-1 min-1)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Intermittent boluses of rocuronium (6.4 +/- 2.3 micrograms kg-1 min-1)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Continuous infusion of rocuronium
Number of subjects: 30

Group type: COMPARATOR
Intervention: Surgical patients receiving comparable infusions
Number of subjects: 30
Study: 1785004

Group type: EXPERIMENTAL
Intervention: Preoperative irradiation (40 Gy) followed by cystectomy
Number of subjects: 183

Group type: COMPARATOR
Intervention: Radical irradiation (60 Gy) followed by salvage cystectomy
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Planned cystectomy
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Radical radiotherapy
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Cystectomy
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Late complications
Number of subjects: 183
Study: 7013307

Group type: EXPERIMENTAL
Intervention: Low carbohydrate diet (refined sugar excluded)
Number of subjects: 20

Group type: COMPARATOR
Intervention: High carbohydrate diet (refined sugar-rich)
Number of subjects: 20
Study: 29738405

Group type: EXPERIMENTAL
Intervention: Group aerobic and strength training (twice weekly for 24 weeks, 60 minutes each session using ankle weights, latex resistance bands, and dumbbells)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (no exercise intervention)
Number of subjects: 52
Study: 30156654

Group type: EXPERIMENTAL
Intervention: Aromatherapy massage with essential oils of lavender and geranium at 1% concentration, six sessions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 26813471

Group type: EXPERIMENTAL
Intervention: Double dose of valsartan (group B)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Double dose of valsartan combined with tacrolimus (group C)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Conventional dose of valsartan (group A)
Number of subjects: 86
Study: 25415738

Group type: EXPERIMENTAL
Intervention: Electromagnetic tracking
Number of subjects: 50
Study: 21416557

Group type: EXPERIMENTAL
Intervention: Dialectical behaviour therapy (DBT)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 25